Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Ten miRNAs may play key roles in starting secondary hair follicle development in sheep foetuses.

Disrupted sleep patterns can harm skin and hair cell renewal, but melatonin might help.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Young women with PCOS and no other heart risk factors have normal heart function.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Genetics, hormones, and microbiome changes contribute to hidradenitis suppurativa.

Omega-6 fats in certain cells boost male hormone production.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

Hormone replacement therapy can improve menopausal skin quality, but it's not recommended just for skin due to limited evidence.